| Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors M Ameratunga, M Chénard-Poirier, IM Candilejo, M Pedregal, A Lui, ... European journal of cancer 89, 56-63, 2018 | 67 | 2018 |
| Ataxia telangiectasia mutated protein loss and benefit from oxaliplatin-based chemotherapy in colorectal cancer R Sundar, S Miranda, DN Rodrigues, M Chénard-Poirier, D Dolling, ... Clinical colorectal cancer 17 (4), 280-284, 2018 | 42 | 2018 |
| Imprecision in the era of precision medicine in non-small cell lung cancer R Sundar, M Chénard-Poirier, DC Collins, TA Yap Frontiers in Medicine 4, 39, 2017 | 26 | 2017 |
| The PI3K pathway at the crossroads of cancer and the immune system: strategies for next generation immunotherapy combinations DC Collins, M Chenard-Poirier, JS Lopez Current Cancer Drug Targets 18 (4), 355-364, 2018 | 24 | 2018 |
| A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials AHI Garces, JE Ang, M Ameratunga, M Chénard-Poirier, D Dolling, ... European Journal of Cancer 104, 32-38, 2018 | 20 | 2018 |
| Immune checkpoint inhibitors in the treatment of gastroesophageal cancer M Chénard-Poirier, EC Smyth Drugs 79 (1), 1-10, 2019 | 19 | 2019 |
| Emerging biomarkers for PD-1 pathway cancer therapy JSJ Lim, R Sundar, M Chénard-Poirier, J Lopez, TA Yap Biomarkers in Medicine 11 (1), 53-67, 2017 | 14 | 2017 |
| Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials R Sundar, T McVeigh, D Dolling, A Petruckevitch, N Diamantis, JE Ang, ... European Journal of Cancer 101, 55-61, 2018 | 6 | 2018 |
| Clinical outcome of patients with advanced biliary tract cancer in a dedicated phase I unit R Sundar, A Custodio, A Petruckevich, M Chénard-Poirier, M Ameratunga, ... Clinical Oncology 30 (3), 185-191, 2018 | 3 | 2018 |
| Gastric Cancers: A Molecular Roadmap for Patient Stratification and Targeted Therapies M Chénard-Poirier, EC Smyth Oncogenomics, 245-256, 2019 | | 2019 |
| Nivolumab for chemorefractory oesophageal squamous cell carcinoma M Chénard-Poirier, EC Smyth Translational Cancer Research 6 (Suppl 7), 2017 | | 2017 |
| ATM protein loss and clinical outcomes with platinum chemotherapy in patients with advanced solid tumors R Sundar, S Miranda, S Carreira, M Chénard-Poirier, DN Rodrigues, ... Cancer Research 77 (13_Supplement), 3807-3807, 2017 | | 2017 |
